John Hamill - Mar 4, 2022 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Role
SVP & CFO
Signature
/s/ John P. Hamill
Stock symbol
WINT
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
4
Date filed
3/7/2022, 04:52 PM
Next filing
Jul 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WINT Common Stock Award $0 +66.3K +1894.29% $0.00 69.8K Mar 4, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WINT Employee Stock Option (Right to Buy) Award $0 +99.6K $0.00 99.6K Mar 4, 2022 Common Stock 99.6K $1.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date.
F2 This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date.